Fresenius Kabi Compounding, LLC FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection OAI · Nov 5, 2025
  • Last warning letter 2026
Inspections 3 1 OAI
Recalls 15 0 Class I (0%)
Warning letters 1 Latest May 12, 2026
510(k) clearances 0 None on file

Fresenius Kabi Compounding, LLC has 15 FDA recalls, 3 inspections, 0 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Fresenius Kabi Compounding, LLC, the most recent on May 12, 2026. FDA has published 1 Form 483 for Fresenius Kabi Compounding, LLC.

What these totals cover: FDA records filed under the name "Fresenius Kabi Compounding, LLC" and its spelling variant "Fresenius Kabi Compounding".

Latest recall
D-0337-2026 · Class II · Feb 5, 2026
Latest inspection
Nov 5, 2025 · OAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls15Nov 15, 2026File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections3Nov 17, 2026Newest record Nov 9, 2026Current
Compliance actions1Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Fresenius Kabi Compounding, LLC's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Fresenius Kabi Compounding, LLC: FDA inspections per year

2017: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 10 recall records (0 Class I) 2025: 1 inspection (1 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 0 inspections (0 OAI), 1 warning letter, 5 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600150
202511000
2024000100
202310000
202200000
202100000
202000000
201900000
201810000
201700000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Fresenius Kabi Compounding, LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Fresenius Kabi Compounding, LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Fresenius Kabi Compounding, LLC FDA Warning Letters

1 warning letter on May 12, 2026.

IssuedSubjectIssuing officeClose-out letter
May 12, 2026 · Record page

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Fresenius Kabi Compounding, LLC Form 483s

1 Form 483 published by FDA.

DateDocumentFEI
Nov 5, 2025 · Document on fda.gov 4833013438665

A Form 483 lists the observations FDA investigators made at the end of an inspection. FDA publishes some Form 483s in its reading room, and each date links to that document. Read the observations with the FDA 483 search.

Recent recalls

15 recall records from Sep 25, 2024 to Feb 5, 2026.

NumberClassProductDate
D-0337-2026Class IIvancomycin HCl, 2 grams, 2 grams added to 500 mL, 0.9% Sodium Chloride Injection, USP, Fagron…Feb 5, 2026
D-0334-2026Class IIketamine HCl, 1,000 mg, 1,000 mg per 100 mL (10 mg per mL) in Sodium Chloride Injection, Fagron…Feb 5, 2026
D-0335-2026Class IIthiamine HCl, 500 mg, 500 mg added to 100 mL, 0.9% Sodium Chloride Injection, USP, Fagron Sterile…Feb 5, 2026
D-0333-2026Class IIacyclovir sodium, 200 mg, 200mg added to 100 mL, 0.9% Sodium Chloride Injection, USP, For…Feb 5, 2026
D-0336-2026Class IIvancomycin HCl, 1.5 grams, 1.5 grams added to 500 mL, 0.9% Sodium Chloride Injection, USP, Fagron…Feb 5, 2026
D-0017-2025Class IIPhenylephrine HCl 0.9% Sodium Chloride Injection USP, 10 mg per 250 mL, Single Dose Bag, Rx only…Sep 25, 2024
D-0021-2025Class IIOxytocin 0.9% Sodium Chloride Injection USP, 30 units per 500 mL Single Dose Bag, Rx only, Fagron…Sep 25, 2024
D-0014-2025Class IIPhenylephrine HCl 0.9% Sodium Chloride Injection USP, 20 mg per 250 mL, Single Dose Bag, Rx only…Sep 25, 2024
D-0018-2025Class IIVancomycin HCl 750 mg per 250 mL 0.9% Sodium Chloride Injection USP, Single Dose Bag, Rx only…Sep 25, 2024
D-0023-2025Class IIThiamine HCl 0.9% Sodium Chloride Injection USP, 500 mg per 100 mL, Single Dose Bag, Rx only, Fagron…Sep 25, 2024
D-0022-2025Class IIEPINEPHrine 0.9% Sodium Chloride Injection USP, 8 mg per 250 mL Single Dose Bag, Rx only, Fagron…Sep 25, 2024
D-0016-2025Class IIPhenylephrine HCl 0.9% Sodium Chloride Injection USP, 10 mg per 250 mL, Single Dose Bag, Rx only…Sep 25, 2024
D-0019-2025Class IINORepinephrine Bitartrate 0.9% Sodium Chloride Injection USP, 4 mg per 250 mL, Single Dose Bag, Rx…Sep 25, 2024
D-0015-2025Class IIPhenylephrine HCl 0.9% Sodium Chloride Injection USP, 20 mg per 250 mL, Single Dose Bag, Rx only…Sep 25, 2024
D-0020-2025Class IINORepinephrine Bitartrate 0.9% Sodium Chloride Injection USP, 8 mg per 250 mL, Single Dose Bag, Rx…Sep 25, 2024

Recent FDA inspections

3 inspections from Dec 4, 2018 to Nov 5, 2025.

DateSiteProductClassificationFEI
Nov 5, 2025Canton, MADrugsOfficial Action Indicated (OAI)3013438665
Mar 6, 2023Canton, MADrugsVoluntary Action Indicated (VAI)3013438665
Dec 4, 2018Canton, MADrugsVoluntary Action Indicated (VAI)3013438665
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 1 compliance action under Fresenius Kabi Compounding, LLC: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, May 12, 2026.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3013438665Canton, MA3Nov 5, 2025

Fresenius Kabi Compounding, LLC and the FDA: common questions

Has Fresenius Kabi Compounding, LLC received an FDA warning letter?

Yes. FDA has issued 1 warning letter to Fresenius Kabi Compounding, LLC. The most recent is dated May 12, 2026.

Has Fresenius Kabi Compounding, LLC received an FDA Form 483?

FDA has published 1 Form 483 for Fresenius Kabi Compounding, LLC in its reading room, the most recent dated Nov 5, 2025. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Fresenius Kabi Compounding, LLC?

The most recent FDA inspection on file ended Nov 5, 2025 at Canton, MA and was classified OAI. FDA has 3 inspections of Fresenius Kabi Compounding, LLC on file, 1 of them classified OAI (official action indicated).

Has Fresenius Kabi Compounding, LLC had an FDA recall?

Yes. Fresenius Kabi Compounding, LLC has 15 FDA recalls on record. The most recent started Feb 5, 2026.

Need more than this page shows? Ask about Fresenius Kabi Compounding, LLC in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.